Skip to main content

Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis: systematic review of cost-effectiveness analysis

Abstract

Background

Transcatheter aortic valve implantation (TAVI) is a less invasive and costly treatment for patients with severe aortic stenosis (AS). This study aimed to systematically review the published literature focusing on economic evaluation of TAVI compared with other alternative treatments in AS populations.

Methods

A systematic review was conducted from inception until May 2021 using PubMed, Scopus, Web of science and Embase databases. The qualities of included studies were evaluated using Consolidated Health Economic Evaluation Reporting Standard (CHEERS) criteria. Data of costs, outcomes, incremental cost-effectiveness ratio (ICER) and willingness to pay were extracted. To compare results, ICERs were converted to the 2020 United States dollar (USD) rate.

Results

Of the 29 included cost-effectiveness studies, TAVI was cost-effective in all studies in the low-risk group (3/3), 77% of studies (7/9) in the intermediate-risk group, half of the studies (6/12) in the high-risk group, and 83% of studies (10/12) in the inoperable group. When adjusted to USD 2020, ICERs ranged from USD 2741 to 1027,674 USD per quality-adjusted life-year gained. The overall quality of the studies ranged from moderate to high.

Conclusions

TAVI is potentially a cost-effective alternative to surgical aortic valve replacement (SAVR) for patients with operable AS with low, intermediate or high risk compared with medical management (MM) for patients with inoperable AS. TAVI was associated with a significant gain in quality-adjusted life-years in almost all studies compared to either SAVR or MM. TAVI is a costly procedure; therefore, justifying its cost-effectiveness depends on the acceptable threshold in each country.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Ancona, R., SC, P.: Epidemiology of aortic valve stenosis (AS) and of aortic valve incompetence (AI): is the prevalence of AS/AI similar in different parts of the world? J. Cardiol. Pract. https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-18/epidemiology-of-aortic-valve-stenosis-as-and-of-aortic-valve-incompetence-ai (2020). Accessed 11 May 2021

  2. Brennan, J.M., Edwards, F.H., Zhao, Y., O’Brien, S.M., Douglas, P.S., Peterson, E.D.: Long-term survival after aortic valve replacement among high-risk elderly patients in the United States: insights from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 1991 to 2007. Circulation 126(13), 1621–1629 (2012)

    Article  Google Scholar 

  3. Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., et al.: 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 43(7), 561–632 (2022)

    Article  Google Scholar 

  4. Otto, C.M., Nishimura, R.A., Bonow, R.O., Carabello, B.A., Erwin, J.P., 3rd., Gentile, F., et al.: 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5), e35–e71 (2021)

    PubMed  Google Scholar 

  5. Leon, M.B., Smith, C.R., Mack, M., Miller, D.C., Moses, J.W., Svensson, L.G., et al.: Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 363(17), 1597–1607 (2010)

    CAS  Article  Google Scholar 

  6. Sakiyalak, P., Slisatkorn, W., Pornratanarangsi, S., Wongpraparut, N., Jakrapanichakul, D., Raksamani, K., et al.: Transcatheter aortic valve implantation (TAVI): first case in Thailand. J Med Assoc Thai. 95(1), 124–128 (2012)

    PubMed  Google Scholar 

  7. Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., et al.: Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 16(2), 231–50 (2013)

    Article  Google Scholar 

  8. Hong, D., Si, L., Jiang, M., Shao, H., Ming, W.K., Zhao, Y., et al.: Cost effectiveness of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase-4 (DPP-4) Inhibitors: a systematic review. Pharmacoeconomics 37(6), 777–818 (2019)

    PubMed  Google Scholar 

  9. Adarkwah, C.C., van Gils, P.F., Hiligsmann, M., Evers, S.M.: Risk of bias in model-based economic evaluations: the ECOBIAS checklist. Expert Rev Pharmacoecon Outcomes Res. 16(4), 513–523 (2016)

    Article  Google Scholar 

  10. Health Quality Ontario: Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment. Ontario Health Technol. Assess. Ser. 16(19), 1–94 (2016)

    Google Scholar 

  11. Brecker, S., Mealing, S., Padhiar, A., Eaton, J., Sculpher, M., Busca, R., et al.: Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open Heart 1(1), e000155 (2014)

    Article  Google Scholar 

  12. Doble, B., Blackhouse, G., Goeree, R., Xie, F.: Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg. 146(1), 52-60.e3 (2013)

    Article  Google Scholar 

  13. Fairbairn, T.A., Meads, D.M., Hulme, C., Mather, A.N., Plein, S., Blackman, D.J., et al.: The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart 99(13), 914–920 (2013)

    Article  Google Scholar 

  14. Freeman, P.M., Protty, M.B., Aldalati, O., Lacey, A., King, W., Anderson, R.A., et al.: Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)-a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data. Open Heart 3(1), e000414 (2016)

    Article  Google Scholar 

  15. Gada, H., Agarwal, S., Marwick, T.H.: Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: outcomes of a decision-analytic model. Ann Cardiothorac Surg 1(2), 145–155 (2012)

    PubMed  PubMed Central  Google Scholar 

  16. Gada, H., Kapadia, S.R., Tuzcu, E.M., Svensson, L.G., Marwick, T.H.: Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol 109(9), 1326–1333 (2012)

    Article  Google Scholar 

  17. Geisler, B.P., Huygens, S.A., Reardon, M.J., Van Mieghem, N., Kappetein, A.P., Osnabrugge, R.L.J., et al.: Cost-effectiveness and projected survival of self-expanding transcatheter versus surgical aortic valve replacement for high risk patients in a European setting: a Dutch analysis based on the corevalve high risk trial. Struct Heart 1(5–6), 267–74 (2017)

    Article  Google Scholar 

  18. Hancock-Howard, R.L., Feindel, C.M., Rodes-Cabau, J., Webb, J.G., Thompson, A.K., Banz, K.: Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings. J Med Econ 16(4), 566–574 (2013)

    Article  Google Scholar 

  19. Inoue, S., Nakao, K., Hanyu, M., Hayashida, K., Shibahara, H., Kobayashi, M., et al.: Cost-effectiveness of transcatheter aortic valve implantation using a balloon-expandable valve in Japan: experience from the Japanese pilot health technology assessment. Value Health Reg Issues 21, 82–90 (2020)

    Article  Google Scholar 

  20. Murphy, A., Fenwick, E., Toff, W.D., Neilson, M.P., Berry, C., Uren, N., et al.: Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom. Int J Technol Assess Health Care 29(1), 12–19 (2013)

    Article  Google Scholar 

  21. Neyt, M., Van Brabandt, H., Devriese, S., Van De Sande, S.: A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2(3), e001032 (2012)

  22. Orlando, R., Pennant, M., Rooney, S., Khogali, S., Bayliss, S., Hassan, A., et al.: Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. Health Technol Assess 17(33), 1–86 (2013)

    CAS  Article  Google Scholar 

  23. Reynolds, M.R., Lei, Y., Wang, K., Chinnakondepalli, K., Vilain, K.A., Magnuson, E.A., et al.: Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement. J Am Coll Cardiol 67(1), 29–38 (2016)

    Article  Google Scholar 

  24. Reynolds, M.R., Magnuson, E.A., Lei, Y., Wang, K., Vilain, K., Li, H., et al.: Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol 60(25), 2683–2692 (2012)

    Article  Google Scholar 

  25. Reynolds, M.R., Magnuson, E.A., Wang, K., Lei, Y., Vilain, K., Walczak, J., et al.: Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 125(9), 1102–1109 (2012)

    Article  Google Scholar 

  26. Simons, C.T., Cipriano, L.E., Shah, R.U., Garber, A.M., Owens, D.K., Hlatky, M.A.: Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes 6(4), 419–428 (2013)

    Article  Google Scholar 

  27. Watt, M., Mealing, S., Eaton, J., Piazza, N., Moat, N., Brasseur, P., et al.: Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 98(5), 370–376 (2012)

    Article  Google Scholar 

  28. Baron, S.J., Wang, K., House, J.A., Magnuson, E.A., Reynolds, M.R., Makkar, R., et al.: Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk. Circulation 139(7), 877–888 (2019)

    Article  Google Scholar 

  29. Geisler, B.P., Jørgensen, T.H., Thyregod, H.G.H., Pietzsch, J.B., Søndergaard, L.: Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients at lower surgical risk: results from the NOTION trial. EuroIntervention 15(11), e959–e967 (2019)

    Article  Google Scholar 

  30. Goodall, G., Lamotte, M., Ramos, M., Maunoury, F., Pejchalova, B., de Pouvourville, G.: Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients. J Med Econ. 22(4), 289–296 (2019)

    Article  Google Scholar 

  31. Kodera, S., Kiyosue, A., Ando, J., Komuro, I.: Cost effectiveness of transcatheter aortic valve implantation in patients with aortic stenosis in Japan. J Cardiol 71(3), 223–229 (2018)

    Article  Google Scholar 

  32. Kuntjoro, I., Tay, E., Hon, J., Yip, J., Kong, W., Poh, K.K., et al.: Cost-effectiveness of transcatheter aortic valve implantation in intermediate and low risk severe aortic stenosis patients in Singapore. Ann Acad Med Singap 49(7), 423–433 (2020)

    Article  Google Scholar 

  33. Ribera, A., Slof, J., Andrea, R., Falces, C., Gutierrez, E., Del Valle-Fernandez, R., et al.: Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants. Int J Cardiol 1(182), 321–328 (2015)

    Article  Google Scholar 

  34. Tam, D.Y., Hughes, A., Fremes, S.E., Youn, S., Hancock-Howard, R.L., Coyte, P.C., et al.: A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk. J Thorac Cardiovasc Surg 155(5), 1978–88.e1 (2018)

    Article  Google Scholar 

  35. Tam, D.Y., Hughes, A., Wijeysundera, H.C., Fremes, S.E.: Cost-effectiveness of self-expandable transcatheter aortic valves in intermediate-risk patients. Ann Thorac Surg 106(3), 676–683 (2018)

    Article  Google Scholar 

  36. Tarride, J.E., Luong, T., Goodall, G., Burke, N., Blackhouse, G.: A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients. Clinicoecon Outcomes Res 11, 477–486 (2019)

    Article  Google Scholar 

  37. Zhou, J., Liew, D., Duffy, S.J., Walton, A., Htun, N., Stub, D.: Cost-effectiveness of transcatheter aortic valve implantation compared to surgical aortic valve replacement in the intermediate surgical risk population. Int J Cardiol 1(294), 17–22 (2019)

    Article  Google Scholar 

  38. Zhou, J.Y., Liew, D., Duffy, S.J., Walton, A., Htun, N., Stub, D.: Cost-effectiveness of transcatheter versus surgical aortic valve replacement in low-risk patients with severe aortic stenosis. Heart Lung Circ 30(4), 547–554 (2021)

    Article  Google Scholar 

  39. Adams, D.H., Popma, J.J., Reardon, M.J., Yakubov, S.J., Coselli, J.S., Deeb, G.M., et al.: Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370(19), 1790–1798 (2014)

    CAS  Article  Google Scholar 

  40. Leon, M.B., Smith, C.R., Mack, M.J., Makkar, R.R., Svensson, L.G., Kodali, S.K., et al.: Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17), 1609–1620 (2016)

    CAS  Article  Google Scholar 

  41. Mack, M.J., Leon, M.B., Thourani, V.H., Makkar, R., Kodali, S.K., Russo, M., et al.: Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380(18), 1695–1705 (2019)

    Article  Google Scholar 

  42. Smith, C.R., Leon, M.B., Mack, M.J., Miller, D.C., Moses, J.W., Svensson, L.G., et al.: Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23), 2187–2198 (2011)

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Dr.Wacin Buddhari for his advice and suggestion.

Funding

The study was supported by a grant from the Health Systems Research Institute (Thailand). The funding source had no influence on the study design, data collection, data analysis, and interpretation.

Author information

Authors and Affiliations

Authors

Contributions

UP initiated the study design and methodology. PC and UP performed the quality assessment. VY and ST performed searching and data extraction. JY assisted in searching database. All authors contributed to the interpretation of the results and development and writing of the draft manuscript and approved the final version.

Corresponding author

Correspondence to Unchalee Permsuwan.

Ethics declarations

Conflict of interest

All authors have no conflicts of interest to declare that are relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Communicated by Sagar Sengupta.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 108 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chotnoppharatphatthara, P., Yoodee, V., Taesotikul, S. et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis: systematic review of cost-effectiveness analysis. Eur J Health Econ (2022). https://doi.org/10.1007/s10198-022-01477-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10198-022-01477-3

Keywords

  • Cost-effectiveness
  • Transcatheter aortic valve implantation
  • Surgical aortic valve replacement
  • Aortic valve stenosis

JEL Classification

  • I18 Government Policy
  • Regulation
  • Public Health